Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

Ames test according to OECD TG 471: negative

Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
15th January to 18th January 2018
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
21st July, 1997
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Version / remarks:
May 30, 2008
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
GLP compliance:
yes (incl. QA statement)
Remarks:
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit
Type of assay:
bacterial reverse mutation assay
Target gene:
His operon
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital and β-naphthoflavone
Test concentrations with justification for top dose:
Experiment I (plate incorporation test): 0.0100, 0.0316, 0.100, 0.316, 1.0, 2.5 and 5.0 µL/plate
Experiment II (pre-incubation test): 0.00316, 0.0100, 0.0316, 0.100, 0.316, 1.0, 2.5 and 5.0 µL/plate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was compatible with the survival of the bacteria and the S9 activity.
Untreated negative controls:
yes
Remarks:
A. dest.
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
sodium azide
methylmethanesulfonate
other: 2-aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar
- Cell density at seeding (if applicable): approx. 10E9 cells/mL

DURATION
- Preincubation period: 60 min for pre-incubation method
- Exposure duration: at least 48 h

NUMBER OF REPLICATIONS: 3

DETERMINATION OF CYTOTOXICITY
- Method: Cytotoxicity was detected by a clearing or rather diminution of the background lawn or a reduction in the number of revertants down to a mutation factor of approximately ≤ 0.5 in relation to the solvent control.
Evaluation criteria:
A test item was considered as mutagenic if:
- a clear and dose-related increase in the number of revertants occurs and/or
- a biologically relevant positive response for at least one of the dose groups occurs in at least one tester strain with or without metabolic activation.

A biologically relevant increase was described as follows:
- if in tester strains TA98, TA100 and TA102 the number of reversions was at least twice as high
- if in tester strains TA 1535 and TA 1537 the number of reversions was at least three times higher than the reversion rate of the solvent control.
Statistics:
Not reported
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
cytotoxic effects at 2.5 µL/plate and higher, ±S9
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
cytotoxic effects at 1.0 µL/plate and higher, ±S9
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
cytotoxic effects at 2.5 µL/plate and higher, ±S9
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
cytotoxic effects at 2.5 µL/plate and higher, ±S9
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
cytotoxic effects at 5.0 µL/plate, ±S9
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation:
No precipitation of the test item was observed in any tester strain used in experiment I and II (with and without metabolic activation).

RANGE-FINDING/SCREENING STUDIES:
Cytotoxicity was observed in both strains (TA98 and TA100) of the preliminary experiment at 5000 µg/plate, ±S9, as evidenced by a reduction in background lawn. Reduced background lawn also was observed at 2500 µg/plate, -S9, for strain TA100.

ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Measurement of cytotoxicity used: Toxicity was detected by a clearing or rather diminution of the background lawn or a reduction in the number of revertants down to a mutation factor of approximately ≤ 0.5 in relation to the solvent control. Toxic effects of the test item were noted in all tester strains evaluated in experiment I and II.
Conclusions:
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, N-{3-[dimethoxy(methyl)silyl]propyl}butan-1-amine did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used. Therefore, N-{3-[dimethoxy(methyl)silyl]propyl}butan-1-amine is considered to be non-mutagenic in this bacterial reverse mutation assay.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

In the Ames assay conducted according to OECD 471 and GLP compliant, the plate incorporation test (Experiment I) and the pre-incubation test (Experiment II) were performed with N-{3-[dimethoxy(methyl)silyl]propyl}butan-1-amine using Salmonella typhimuriumstrains TA98, TA100, TA1535, TA1537 and TA102 with and without metabolic activation (Eurofins, 2018). The following concentrations of the test item were used in the experiments: 0.0100, 0.0316, 0.100, 0.316, 1.0, 2.5 and 5.0 µL/plate for Experiment I; and 0.00316, 0.0100, 0.0316, 0.100, 0.316, 1.0, 2.5 and 5.0 µL/plate for Experiment II.


No precipitation of the test item was observed in any tester strain used in experiment I and II (with and without metabolic activation). Cytotoxicity was observed in both experiments. In Experiment I, toxic effects of the test item were observed at concentrations of 2.5 µL/plate and higher, -S9, and at a concentration of 5.0 µl/plate, +S9, depending on the particular tester strain. In Experiment II toxic effects of the test item were noted at concentrations of 1.0 µL/plate and higher, -S9, and at concentrations of 2.5 µL/plate and higher, +S9, depending on the particular tester strain.


No biologically relevant increases in revertant colony numbers of any of the five tester strains were observed following treatment with N-{3-[dimethoxy(methyl)silyl]propyl}butan-1-amine at any concentration level, neither in the presence nor absence of metabolic activation in experiment I and II. In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, N-{3-[dimethoxy(methyl)silyl]propyl}butan-1-amine did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used. Therefore, N-{3-[dimethoxy(methyl)silyl]propyl}butan-1-amine is considered to be non-mutagenic in this bacterial reverse mutation assay.

Justification for classification or non-classification

Based on the available data on genetic toxicity, there is no indication that N-{3-[dimethoxy(methyl)silyl]propyl}butan-1-amine induces genetic toxicity in bacteria. However, no final decision on classification for genetic toxicity according to Regulation (EC) No. 1272/2008 can be made, as no information on chromosomal aberration and mutagenicity in mammalian cells/in vivo is available.